Marc S. Sabatine

Also affiliated with Thrombolysis in Myocardial Infarction Study Group

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 45 papers. Top paper: “Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update”.

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2526

N/A

8.6DataRank · unranked

473 citations

Jasmine A. Luzum, Katrin Sangkuhl, Roseann S. Gammal, Marc S. Sabatine, Charles Michael Stein +12 more

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants

Nature Genetics(2022)10.1038/s41588-022-01233-6

N/A

7.7DataRank · unranked

721 citations

Tao Jiang, Anuj Goel, Stavroula Kanoni, Brooke N. Wolford, Deepak Atri +92 more

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

JAMA(2020)10.1001/jama.2020.1906

N/A

6.7DataRank · unranked

539 citations

Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek +34 more

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan

JACC Heart Failure(2020)10.1016/j.jchf.2020.04.008

N/A

5.0DataRank · unranked

142 citations

Pardeep S. Jhund, Brian Claggett, Pooja Dewan, Lars Køber, Mikhail Kosiborod +11 more

Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF

Circulation(2022)10.1161/circulationaha.121.058910

N/A

4.7DataRank · unranked

131 citations

Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi +16 more

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT

Circulation(2022)10.1161/circulationaha.122.061533

N/A

2.8DataRank · unranked

82 citations

David D. Berg, Mathew S. Lopes, Jean M. Connors, Ijlal Babar, Christopher F. Barnett +94 more

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Diabetes Care(2020)10.2337/dc20-1675

N/A

2.7DataRank · unranked

76 citations

Kieran F. Docherty, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski +16 more

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF

Circulation(2021)10.1161/circulationaha.121.053659

N/A

2.5DataRank · unranked

60 citations

Piotr Ponikowski, Kieran F. Docherty, Samvel B. Gasparyan, Michael Böhm, Chern‐En Chiang +16 more

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF

European Journal of Heart Failure(2020)10.1002/ejhf.2083

N/A

1.7DataRank · unranked

48 citations

Kieran F. Docherty, Olof Bengtsson, Rudolf A. de Boer, Akshay S. Desai, Jarosław Dróżdż +19 more

Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score

JACC Heart Failure(2022)10.1016/j.jchf.2022.03.009

N/A

1.4DataRank · unranked

29 citations

Pooja Dewan, Ersilia M. DeFilippis, Tor Biering‐Sørensen, Kieran F. Docherty, Pardeep S. Jhund +13 more

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

European Heart Journal(2019)10.1093/eurheartj/ehz455

N/A

1.4DataRank · unranked

8683 citations

Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, M. John Chapman +138 more

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine(2019)10.1056/nejmoa1911303

N/A

1.3DataRank · unranked

5622 citations

Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez +43 more

Patient Characteristics, Clinical Outcomes, and Effect of Dapagliflozin in Relation to Duration of Heart Failure

Circulation Heart Failure(2020)10.1161/circheartfailure.120.007879

N/A

1.1DataRank · unranked

27 citations

Pooja Dewan, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +9 more

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: comparing and contrasting guidance across the Atlantic

European Heart Journal(2017)10.1093/eurheartj/ehw572

N/A

1.1DataRank · unranked

18 citations

Marc S. Sabatine

Relationship of Dapagliflozin With Serum Sodium

JACC Heart Failure(2022)10.1016/j.jchf.2022.01.019

N/A

0.999DataRank · unranked

31 citations

Kieran F. Docherty, Pardeep S. Jhund, Mark C. Petrie, Silvio E. Inzucchi, Lars Køber +12 more

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.08.006

N/A

0.900DataRank · unranked

49 citations

Modele O. Ogunniyi, Inder S. Anand, Akshay S. Desai, Mirta Díez, Jonathan G. Howlett +17 more

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Circulation(2025)10.1161/circulationaha.125.076575

N/A

0.794DataRank · unranked

37 citations

Siddharth M. Patel, Paul M. Haller, Abby L. Cange, Michael G. Palazzolo, Andrea Bellavia +23 more

Biomarkers of platelet activation and cardiovascular risk in the DAPT trial

Journal of Thrombosis and Thrombolysis(2020)10.1007/s11239-020-02221-5

N/A

0.721DataRank · unranked

14 citations

Robert W. Yeh, Laura Mauri, David A. Morrow, Dean J. Kereiakes, Donald E. Cutlip +8 more

Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HF

JACC Heart Failure(2022)10.1016/j.jchf.2021.09.002

N/A

0.614DataRank · unranked

13 citations

Joanne Simpson, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod +10 more

Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial

American Heart Journal(2025)10.1016/j.ahj.2025.02.022

N/A

0.453DataRank · unranked

12 citations

Nicholas Marston, Thomas A Prohaska, Veronica J. Alexander, André Zimerman, Filipe A. Moura +9 more

Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia

American Heart Journal(2025)10.1016/j.ahj.2025.03.003

N/A

0.408DataRank · unranked

10 citations

Brian A. Bergmark, Veronica J. Alexander, Ewa Karwatowska‐Prokopczuk, Yu Mi Kang, Filipe A. Moura +8 more

Galectin-3 and Kidney Function in Type 2 Diabetes Treated with Dapagliflozin: Analysis from DECLARE-TIMI 58

ESC Heart Failure(2025)10.1002/ehf2.15415

N/A

0.220DataRank · unranked

3 citations

Stephen D. Wiviott, David D. Berg, Petr Jarolı́m, Erica L. Goodrich, Deepak L. Bhatt +8 more

Plasma extracellular vesicle cargo microRNAs are associated with heart failure and cardiovascular death following acute coronary syndrome

Extracellular Vesicle(2025)10.1016/j.vesic.2025.100070

N/A

0DataRank · unranked

4 citations

Michael G. Silverman, Nedyalka Valkov, Jeong‐Gun Park, Ashish Yeri, Fernando Camacho Garcia +17 more

Statistical approaches for systematically missing covariates in individual participant data meta-analysis: insights and applications using 5 large cardiovascular trials

American Journal of Epidemiology(2025)10.1093/aje/kwaf226

N/A

0DataRank · unranked

0 citations

Paul M. Haller, Siddharth M. Patel, Erin A. Bohula, David A. Morrow, Sabina A. Murphy +7 more

Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease

Circulation Genomic and Precision Medicine(2021)10.1161/circgen.120.003006

N/A

0DataRank · unranked

14 citations

Giorgio Melloni, Yared Gurmu, Marc P. Bonaca, Frederick Kamanu, Carolina Roselli +17 more

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants

medRxiv(2021)10.1101/2021.05.24.21257377

N/A

0DataRank · unranked

69 citations

Tao Jiang, Anuj Goel, Stavroula Kanoni, Brooke N. Wolford, Elle M. Weeks +87 more

A polygenic risk score predicts atrial fibrillation in cardiovascular disease

European Heart Journal(2022)10.1093/eurheartj/ehac460

N/A

0DataRank · unranked

82 citations

Amanda C. Garfinkel, Frederick Kamanu, Giorgio Melloni, Carolina Roselli, Petr Jarolı́m +15 more

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Circulation(2022)10.1161/circulationaha.122.062832

N/A

0DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Sheila M. Hegde, Maria Pabón, Ian J. Kulac +22 more

Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genes

Nature Communications(2022)10.1038/s41467-022-32009-5

N/A

0DataRank · unranked

10 citations

Valerie N. Morrill, Seung Hoan Choi, Sean J. Jurgens, Giorgio Melloni, Nicholas Marston +39 more

Lipoprotein(a) and Benefit of Antiplatelet Therapy

JACC Advances(2023)10.1016/j.jacadv.2023.100675

N/A

0DataRank · unranked

14 citations

Marc P. Bonaca, David A. Morrow, Michael G. Palazzolo, Petr Jarolı́m, Philippe Gabríel Steg +5 more

Impaired angiogenesis in diabetic critical limb ischemia is mediated by a miR-130b/INHBA signaling axis

JCI Insight(2023)10.1172/jci.insight.163041

N/A

0DataRank · unranked

13 citations

Daniel Pérez‐Cremades, Rulin Zhuang, Anurag Jamaiyar, Winona Wu, Jingshu Chen +10 more

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

Diabetes Care(2023)10.2337/dc23-0492

N/A

0DataRank · unranked

14 citations

David D. Berg, Andrea Bellavia, Jamie P. Dwyer, Ofri Mosenzon, Benjamin M. Scirica +8 more

A miRNA/CXCR4 signaling axis impairs monopoiesis and angiogenesis in diabetic critical limb ischemia

JCI Insight(2023)10.1172/jci.insight.163360

N/A

0DataRank · unranked

10 citations

Rulin Zhuang, Daniel Pérez‐Cremades, Jingshu Chen, Anurag Jamaiyar, Winona Wu +10 more

Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61

European Journal of Heart Failure(2023)10.1002/ejhf.3118

N/A

0DataRank · unranked

9 citations

David A. Morrow, Andrea Bellavia, David D. Berg, Deepak L. Bhatt, Petr Jarolı́m +11 more

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation(2024)10.1161/circulationaha.124.069568

N/A

0DataRank · unranked

168 citations

Yu Mi Kang, KyungAh Im, Brendon L. Neuen, Stefan D. Anker, Deepak L. Bhatt +24 more

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00040-8

N/A

0DataRank · unranked

143 citations

David Preiss, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies +95 more

Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials

Nature Medicine(2024)10.1038/s41591-024-03188-z

N/A

0DataRank · unranked

42 citations

James P. Pirruccello, Giorgio Melloni, Frederick Kamanu, Marc P. Bonaca, Robert P. Giugliano +12 more

Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2023.09.836

N/A

0DataRank · unranked

35 citations

Giorgio Melloni, Sabina A. Murphy, Jakub Morze, Frederick Kamanu, Patrick T. Ellinor +3 more

Deficiency of lncRNA MERRICAL abrogates macrophage chemotaxis and diabetes-associated atherosclerosis

Cell Reports(2024)10.1016/j.celrep.2024.113815

N/A

0DataRank · unranked

16 citations

Anurag Jamaiyar, Winona Wu, Yi Hu, Rulin Zhuang, Grasiele Sausen +14 more

Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3263

N/A

0DataRank · unranked

14 citations

Toru Kondo, Atefeh Talebi, Pardeep S. Jhund, Kieran F. Docherty, Brian Claggett +15 more

Dapagliflozin in Patients with Heart Failure and Previous Myocardial Infarction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER

European Journal of Heart Failure(2024)10.1002/ejhf.3184

N/A

0DataRank · unranked

11 citations

Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Alberto Foà, Akshay S. Desai +17 more

Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease

European Heart Journal(2024)10.1093/eurheartj/ehae780

N/A

0DataRank · unranked

8 citations

Mats Christian Højbjerg Lassen, Brian Claggett, Zi Michael Miao, Silvio E. Inzucchi, Kieran F. Docherty +16 more

Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy

Diabetes Obesity and Metabolism(2024)10.1111/dom.15798

N/A

0DataRank · unranked

2 citations

Andrea Bellavia, David D. Berg, Giorgio Melloni, Mark W. Feinberg, Lawrence A. Leiter +6 more

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers

Diabetes Obesity and Metabolism(2024)10.1111/dom.16123

N/A

0DataRank · unranked

2 citations

Frederick Kamanu, Stephen D. Wiviott, Robert P. Giugliano, Miriam S. Udler, Jose C. Florez +5 more

A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk

Journal of the American College of Cardiology(2025)10.1016/j.jacc.2025.06.050

N/A

0DataRank · unranked

5 citations

Giorgio Melloni, David D. Berg, Frederick Kamanu, Yi-Pin Lai, Elliott M. Antman +17 more